Fulgent Genetics (FLGT) Interest & Investment Income (2016 - 2026)
Fulgent Genetics' Interest & Investment Income history spans 12 years, with the latest figure at $8.7 million for Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 7.89% to $8.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $31.6 million, a 1.21% decrease, with the full-year FY2025 number at $30.9 million, down 1.23% from a year prior.
- Interest & Investment Income hit $8.7 million in Q1 2026 for Fulgent Genetics, up from $6.9 million in the prior quarter.
- Over the last five years, Interest & Investment Income for FLGT hit a ceiling of $8.7 million in Q1 2026 and a floor of $45000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $5.7 million across 5 years, with a median of $6.9 million in 2025.
- The widest YoY moves for Interest & Investment Income: up 9288.57% in 2022, down 84.04% in 2022.
- Tracing FLGT's Interest & Investment Income over 5 years: stood at $3.2 million in 2022, then surged by 80.66% to $5.8 million in 2023, then surged by 39.81% to $8.1 million in 2024, then decreased by 14.61% to $6.9 million in 2025, then grew by 24.73% to $8.7 million in 2026.
- Business Quant data shows Interest & Investment Income for FLGT at $8.7 million in Q1 2026, $6.9 million in Q4 2025, and $7.9 million in Q3 2025.